文献速递区域麻醉与超声疼痛医学

颗粒型皮质类固醇稀释与微滤对脊髓硬膜外注射药物浓度及团聚的影响

Dilution and microfiltration of particulate corticosteroids for spinal epidural injections: impact on drug concentration and agglomerate formation.
PubMed 文献 · Anaesthesia · 2019-06-22

该研究将曲安奈德和醋酸甲泼尼龙两种颗粒型皮质类固醇与布比卡因或生理盐水混合,通过5微米和0.2微米过滤器后检测。质谱显示两种过滤器均导致皮质类固醇完全丢失,光镜显示团聚形成,提示过滤干扰药物剂量,稀释剂选择也需考虑以减少大团聚。

要点

  • 颗粒型皮质类固醇经过5微米或0.2微米过滤器后药物完全丢失
  • 过滤后光镜可见团聚体形成,影响药物剂量
  • 稀释剂选择影响大团聚体形成,需谨慎选择

核心结论

  • 过滤颗粒型皮质类固醇悬浮液会导致药物完全丢失并形成团聚体,干扰药物剂量。

研究设计与样本

  • 体外实验研究,两种颗粒型皮质类固醇以不同浓度与布比卡因或0.9%氯化钠混合,通过5微米和0.2微米过滤器。

主要发现

  • 质谱结果显示使用两种过滤器后溶液中皮质类固醇完全丢失。
  • 光镜成像显示团聚体形成,提示过滤干扰药物剂量。
  • 稀释剂选择需考虑以减少大团聚体形成。

临床怎么用

  • 临床医生应知晓过滤颗粒型悬浮液的后果,制定治疗计划时仔细考虑稀释剂选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Particulate corticosteroids have been described to lead to greater pain improvement compared with their non-particulate counterparts when used in epidural injections. It is hypothesised that filtering may significantly impact their concentration and long-term efficacy. We investigated if passing particulate suspensions through different commonly-used filters affects drug dosage. Two particulate corticosteroid formulations, triamcinolone acetonide and methylprednisolone acetate, were mixed at different concentrations with either bupivacaine hydrochloride or 0.9% sodium chloride. Solutions were passed through a 5-μm and a 0.2-μm filter. Mass spectroscopy results indicated a complete loss of corticosteroid from the solutions using both filters, and light microscopy imaging demonstrated agglomerate formation, suggesting that filtering interferes with drug dosage. The choice of diluents must also be considered to reduce large agglomerate formation. Clinicians should be aware of the consequences of filtering particulate suspensions and carefully consider the selection of diluent when considering treatment plans.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Alcántara Guardado A, Cooper G, Weightman A, et al. Dilution and microfiltration of particulate corticosteroids for spinal epidural injections: impact on drug concentration and agglomerate formation. Anaesthesia. 2019. PMID: 31228255. doi:10.1111/anae.14733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。